Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6382 USD | +2.59% |
|
-0.36% | -15.64% |
Business Summary
Number of employees: 22
Managers
Managers | Title | Age | Since |
---|---|---|---|
Leonard Mazur
CEO | Chief Executive Officer | 79 | 13-06-30 |
Jaime Bartushak
DFI | Director of Finance/CFO | 57 | 17-11-26 |
Preeti Singh
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Myron Czuczman
CTO | Chief Tech/Sci/R&D Officer | 65 | 20-07-13 |
Alan Lader
CTO | Chief Tech/Sci/R&D Officer | - | 16-02-29 |
Gary Talarico
COO | Chief Operating Officer | 69 | 16-02-29 |
Myron Holubiak
BRD | Director/Board Member | 77 | 15-09-30 |
Ilanit Allen
IRC | Investor Relations Contact | - | 21-05-16 |
General Counsel | - | 22-02-09 | |
Paul Sowyrda
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Myron Holubiak
BRD | Director/Board Member | 77 | 15-09-30 |
Dennis McGrath
BRD | Director/Board Member | 67 | 23-02-06 |
Leonard Mazur
CEO | Chief Executive Officer | 79 | 13-06-30 |
Carol Webb
BRD | Director/Board Member | 78 | 16-02-29 |
Suren Dutia
BRD | Director/Board Member | 82 | 15-09-30 |
Eugene Holuka
BRD | Director/Board Member | 65 | 16-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 180,673,355 | 168,365,416 ( 93.19 %) | 0 | 93.19 % |
Company contact information
Citius Pharmaceuticals, Inc.
11 Commerce Drive 1st floor
07016, Cranford
+908 967 6677
http://www.citiuspharma.com![address Citius Pharmaceuticals, Inc.(CTXR)](https://cdn.zonebourse.com/static/address/37333404.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.64% | 112M | |
+21.85% | 46.93B | |
+37.63% | 39.08B | |
-8.05% | 38.48B | |
+29.04% | 31.01B | |
-13.75% | 26.14B | |
+10.65% | 25.88B | |
+38.43% | 12.53B | |
-6.92% | 11.36B | |
-12.29% | 10.65B |
- Stock Market
- Equities
- CTXR Stock
- Company Citius Pharmaceuticals, Inc.